Hybrid Conferencee

International Conference on Neurodegenerative Disorders and Research (ICNDRR - 27)

14th - 15th January 2027 | Doha, Qatar
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 14–15 January 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 3 SDGs SDGs 3, 4 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

14 JAN 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Pathophysiology of Neurodegenerative Disorders
    34
    Track Overview

    This session will explore the underlying biological mechanisms contributing to neurodegenerative diseases, focusing on cellular and molecular pathways. Emphasis will be placed on the role of neuroinflammation and oxidative stress in the progression of disorders such as Alzheimer's and Parkinson's.

    Track 02
    Advancements in Alzheimer's Disease Research
    34
    Track Overview

    This track will highlight recent breakthroughs in the understanding and treatment of Alzheimer's disease. Discussions will include novel biomarkers, therapeutic strategies, and the impact of lifestyle factors on disease progression.

    Track 03
    Innovative Approaches to Parkinson's Disease Management
    34
    Track Overview

    This session will focus on cutting-edge research and clinical practices aimed at improving the quality of life for individuals with Parkinson's disease. Topics will include pharmacological advancements, non-pharmacological interventions, and patient-centered care models.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Neurobiology of Dementia: Mechanisms and Implications
    34
    Track Overview

    This track will delve into the neurobiological changes associated with various forms of dementia, including Alzheimer's and vascular dementia. Presentations will cover synaptic dysfunction, neuronal loss, and the implications for therapeutic interventions.

    Track 05
    Clinical Trials in Neurodegenerative Disorders
    39
    Track Overview

    This session will provide insights into the design, execution, and outcomes of clinical trials focused on neurodegenerative diseases. Participants will discuss challenges in recruitment, endpoint selection, and regulatory considerations.

    Track 06
    Neuroprotective Strategies and Therapeutic Approaches
    34
    Track Overview

    This track will examine potential neuroprotective strategies aimed at slowing the progression of neurodegenerative diseases. Topics will include pharmacological agents, lifestyle modifications, and emerging therapies.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
View Day 02 Schedule →
Day 02

Keynote, Technical Sessions & Awards

15 JAN 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Genetic and Environmental Factors in Neurodegeneration
    34
    Track Overview

    This session will explore the interplay between genetic predispositions and environmental influences in the development of neurodegenerative disorders. Discussions will focus on gene-environment interactions and their implications for prevention and treatment.

    Track 08
    Neuroimaging Techniques in Neurodegenerative Research
    34
    Track Overview

    This track will highlight the role of advanced neuroimaging techniques in the study of neurodegenerative disorders. Presentations will cover the use of MRI, PET, and other imaging modalities to assess disease progression and treatment efficacy.

    Track 09
    Cognitive and Behavioral Aspects of Neurodegenerative Disorders
    34
    Track Overview

    This session will address the cognitive and behavioral changes associated with neurodegenerative diseases, emphasizing the need for comprehensive assessment and intervention strategies. Topics will include neuropsychological testing and psychosocial support.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Translational Research in Neuroscience
    34
    Track Overview

    This track will focus on the translation of basic neuroscience research into clinical applications for neurodegenerative disorders. Emphasis will be placed on collaborative efforts between researchers and clinicians to bridge the gap between laboratory findings and patient care.

    Track 11
    Future Directions in Neurodegenerative Disorder Research
    34
    Track Overview

    This session will explore emerging trends and future directions in the research of neurodegenerative disorders. Discussions will include innovative technologies, interdisciplinary approaches, and the potential for personalized medicine.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
← Back to Day 01 Schedule
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure

Be Part of ICNDRR-27

Submit your research or complete your conference registration.

Submit Abstract / Paper Complete Registration
Copyrights © . All Rights Reserved. Terms & Conditions